financetom
Business
financetom
/
Business
/
Newell Brands Lowers 2025 Outlook as Third-Quarter Results Miss Street Views Amid Tariff Impact
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Newell Brands Lowers 2025 Outlook as Third-Quarter Results Miss Street Views Amid Tariff Impact
Oct 31, 2025 8:02 AM

10:35 AM EDT, 10/31/2025 (MT Newswires) -- Newell Brands ( NWL ) lowered its full-year outlook on Friday as the consumer products manufacturer's third-quarter results missed market expectations amid significant trade disruptions, tariff impact and weakness in international markets.

The maker of Sharpie markers now anticipates adjusted earnings to come in between $0.56 and $0.60 per share for 2025, down from its previous projections of $0.66 to $0.70. Sales are pegged to decline by 4.5% to 5% for the year, compared with the prior guidance for a 2% to 3% decrease. The current consensus on FactSet is for non-GAAP EPS of $0.67 and sales of $7.35 billion.

Shares of the company tumbled 30% in Friday trade. The stock has plunged 67% so far this year.

Tariffs are now expected to cost Newell about $180 million for the current year, up from its previous estimate of a $155 million headwind. "The increase is driven by higher import volumes from China following our second quarter shipment pause, additional reciprocal tariffs on Southeast Asia and China," Chief Financial Officer Mark Erceg said during an earnings call, according to a FactSet transcript.

Earlier in the week, US President Donald Trump reportedly said he would lower tariffs on China to 47% from 57% after concluding trade talks with his Chinese counterpart, Xi Jinping, in South Korea.

For the fourth quarter, Newell forecasts adjusted EPS to be in a range of $0.16 to $0.20 and sales to be down 1% to 4%. The Street is looking for non-GAAP EPS of $0.27 and sales of $1.96 billion.

The company expects its international business to "return to growth" in the ongoing three-month period, while its "competitive pricing actions are gaining traction," especially in categories like writing, Chief Executive Chris Peterson said in the earnings release. "We are confident that our decisive actions are paving the way for the company to return to sustainable top-line growth in the future," according to Peterson.

Newell anticipates to have "more incremental tariff advantaged wins in the fourth quarter than in the third," Erceg said on the call.

The company's adjusted EPS ticked up to $0.17 in the September quarter from $0.16 the year before, but missed the average analyst estimate of $0.18. Sales fell 7.2% to $1.81 billion, trailing the market view for $1.89 billion. Core sales were down 7.4% on a yearly basis.

The broader industry suffered from significant trade disruptions in the quarter, while the company implemented pricing actions and productivity initiatives to "mitigate the impact," Peterson said. "Sales were affected by reduced retail inventory levels, softness in international markets - particularly in Brazil - and moderated demand following tariff driven pricing actions," the CEO added.

Core sales in Newell's home and commercial solutions segment declined 9.8%, while the learning and development division saw core sales fall 5.6%. Core sales in the outdoor and recreation business edged down 0.9%. All three segments benefited from foreign exchange, the company said.

Price: 3.15, Change: -1.57, Percent Change: -33.26

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cyclo Therapeutics Granted Patent Covering Use of Trappsol Cyclo for Alzheimer's Disease
Cyclo Therapeutics Granted Patent Covering Use of Trappsol Cyclo for Alzheimer's Disease
Mar 14, 2024
10:58 AM EDT, 03/14/2024 (MT Newswires) -- Cyclo Therapeutics ( CYTH ) said Thursday the US Patent and Trademark Office granted a patent that covers the use of Trappsol Cyclo for the prevention and treatment of early onset Alzheimer's disease. Shares of the company fell 1.8% in recent trading. Price: 1.59, Change: -0.03, Percent Change: -1.85 ...
Fitch Assigns Rating to Baytex Energy's Senior Unsecured Notes
Fitch Assigns Rating to Baytex Energy's Senior Unsecured Notes
Mar 14, 2024
10:58 AM EDT, 03/14/2024 (MT Newswires) -- Fitch Ratings said Thursday that it has assigned a BB-/RR3 rating to Baytex Energy's ( BTE ) proposed senior unsecured notes offering. The company plans to use the net proceeds to redeem the company's 8.75% 2027 senior notes and repay a portion of credit facility borrowings. The notes will be guaranteed by all...
Paycor HCM Chosen as Human Resources, Payroll Provider for Los Angeles Rams
Paycor HCM Chosen as Human Resources, Payroll Provider for Los Angeles Rams
Mar 14, 2024
11:00 AM EDT, 03/14/2024 (MT Newswires) -- Paycor HCM ( PYCR ) has entered into a multiyear partnership to be the official human resources and payroll provider for the Los Angeles Rams, SoFi Stadium and Hollywood Park, according to a statement Thursday. The company's HR software will be used to help streamline workflows and enhance people management at the three...
Better Therapeutics to Terminate Employees, Explore Strategic Alternatives; Shares Drop Sharply
Better Therapeutics to Terminate Employees, Explore Strategic Alternatives; Shares Drop Sharply
Mar 14, 2024
10:59 AM EDT, 03/14/2024 (MT Newswires) -- Better Therapeutics ( BTTX ) shares were down more than 83% in recent trading Thursday after the company announced it is terminating its employees and will explore strategic alternatives. Options include the assignment for the benefit of creditors and/or a wind-down of the company, Better Therapeutics ( BTTX ) said. The decision was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved